{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:36:58Z","timestamp":1785307018330,"version":"3.55.0"},"reference-count":177,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.clindermatol.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T19:54:23Z","timestamp":1571169263000},"page":"692-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Advances in the diagnosis of autoimmune bullous dermatoses"],"prefix":"10.1016","volume":"37","author":[{"given":"Jane","family":"Harrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiomara Brioso","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colton","family":"Nielson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Motaparthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.clindermatol.2019.09.004_bb0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000246955","article-title":"A retrospective analysis of tissue-fixed immunoreactants from skin biopsies maintained in Michel\u2019s medium","volume":"189","author":"Vaughan Jones","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2229-5178.198774","article-title":"Utility of immunofluorescence in dermatology","volume":"8","author":"Shetty","year":"2017","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2010.06.019","article-title":"Can direct immunofluorescence testing still be accurate if performed on biopsy specimens after brief inadvertent immersion in formalin?","volume":"65","author":"Arbesman","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0020","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1038\/jid.2013.287","article-title":"Enzyme immunoassay and enzyme-linked immunosorbent assay","volume":"133","author":"Gan","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0025","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archderm.138.9.1252","article-title":"Limitations in enzyme-linked immunosorbent assays for antibodies against desmogleins 1 and 3 in patients with pemphigus","volume":"138","author":"Bystryn","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0003-2697(81)90281-5","article-title":"\u201cWestern blotting\u201d: electrophoretic transfer of proteins from sodium dodecyl sulfate\u2014polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A","volume":"112","author":"Burnette","year":"1981","journal-title":"Anal Biochem"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-4939-6990-6_9","article-title":"Western blot techniques","volume":"1606","author":"Kim","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0040","unstructured":"US Centers for Medicare and Medicaid Services. Clinical diagnostic laboratory fee schedule. Available at: https:\/\/www.cms.gov\/Medicare\/Medicare-Fee-for-Service-Payment\/ClinicalLabFeeSched\/index.html. Accessed."},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0045","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/cup.12384","article-title":"Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus","volume":"41","author":"Ohata","year":"2014","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0050","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1600-0625.2010.01069.x","article-title":"Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients","volume":"19","author":"Schmidt","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.autrev.2012.07.006","article-title":"Diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-skin autoantibodies in autoimmune blistering skin diseases: a systematic review and meta-analysis","volume":"12","author":"Tampoia","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0060","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/DAD.0000000000000889","article-title":"Efficacy of triaging direct immunofluorescence in intraepidermal bullous dermatoses","volume":"40","author":"Tjarks","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0070","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/0019-5154.182422","article-title":"A clinicopathological study of pemphigus in Eastern India with special reference to direct immunofluorescence","volume":"61","author":"Chowdhury","year":"2016","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0075","doi-asserted-by":"crossref","unstructured":"Caproni M, Giomi B, Cardinali C, et al. Further support for a role for Th2-like cytokines in blister formation of pemphigus. Clinical Immunology [serial on the Internet]. 2001;98(2).","DOI":"10.1006\/clim.2000.4974"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0080","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/0019-5154.135488","article-title":"A cross-sectional study of direct immunofluorescence in the diagnosis of immunobullous dermatoses","volume":"59","author":"Buch","year":"2014","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0085","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1346-8138.1995.tb03876.x","article-title":"Immunofluorescence study of pemphigus from north India","volume":"22","author":"Kumar","year":"1995","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0090","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1590\/abd1806-4841.20143221","article-title":"Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience","volume":"89","author":"Arbache","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0095","first-page":"243","article-title":"A study of clinical, histopathological and direct immunofluorescence diagnosis in pemphigus group Utility of direct immunofluorescence","volume":"118","author":"Hrabovska","year":"2017","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0100","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4103\/2229-5178.156386","article-title":"Role of direct immunofluorescence in dermatological disorders","volume":"6","author":"Mysorekar","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0105","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/archderm.1977.01640120064011","article-title":"Pemphigus foliaceus associated with absence of intercellular antigens in lower layers of epidermis","volume":"113","author":"Rodriguez","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1440-0960.2005.00191.x","article-title":"Comparison of desmoglein ELISA and indirect immunofluorescence using two substrates (monkey oesophagus and normal human skin) in the diagnosis of pemphigus","volume":"46","author":"Ng","year":"2005","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-4632.2004.02541.x","article-title":"A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris","volume":"44","author":"Zagorodniuk","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0120","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1046\/j.1365-2133.2000.03538.x","article-title":"The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus","volume":"142","author":"Harman","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/ijd.IJD_595_16","article-title":"Comparison of immunofluorescence and desmoglein enzyme-linked immunosorbent assay in the diagnosis of pemphigus: a prospective, cross-sectional study in a tertiary care hospital","volume":"62","author":"Ravi","year":"2017","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fmed.2018.00266","article-title":"The usefulness of indirect immunofluorescence in pemphigus and the natural history of patients with initial false-positive results: a retrospective cohort study","volume":"5","author":"Kridin","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(97)80127-2","article-title":"Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus","volume":"37","author":"Jiao","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3389\/fimmu.2018.00839","article-title":"Keratinocyte binding assay identifies anti-desmosomal pemphigus antibodies where other tests are negative","volume":"9","author":"Giurdanella","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0145","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0378-6323.58675","article-title":"Comparison of enzyme-linked immunosorbent assay test with immunoblot assay in the diagnosis of pemphigus in Indian patients","volume":"76","author":"Khandpur","year":"2010","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0150","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2340\/00015555-2023","article-title":"Autoantibody levels and clinical disease severity in patients with pemphigus: comparison of aggregated anti-desmoglein ELISA values and indirect immunofluorescence titres","volume":"95","author":"Weiss","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0155","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0160","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ced.12187","article-title":"Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris","volume":"39","author":"Daneshpazhooh","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0170","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/ijd.12768","article-title":"Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity","volume":"54","author":"Barnadas","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008801","article-title":"Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission","volume":"96","author":"Russo","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0180","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/jop.12439","article-title":"Comparative study of indirect immunofluorescence, enzyme-linked immunosorbent assay, and the Tzanck smear test for the diagnosis of pemphigus","volume":"45","author":"Zhou","year":"2016","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0185","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/bjd.12925","article-title":"Clinical and immunological profiles in 17 Japanese patients with drug-induced pemphigus studied at Kurume University","volume":"171","author":"Yoshimura","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12748","article-title":"Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: a case series and literature review","volume":"32","author":"Palleria","year":"2019","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0195","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1309\/3CAKPEU8JXGWLEDC","article-title":"Immunostaining with antibodies to desmoglein provides the diagnosis of drug-induced pemphigus and allows prediction of outcome","volume":"130","author":"Maruani","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0200","first-page":"735","article-title":"Detection of IgA autoantibodies to desmogleins by an enzyme-linked immunosorbent assay: the presence of new minor subtypes of IgA pemphigus","volume":"137","author":"Hashimoto","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0205","first-page":"626","article-title":"IgA pemphigus reacting exclusively to desmoglein 3","volume":"20","author":"Tajima","year":"2010","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5826\/dpc.0604a07","article-title":"IgA pemphigus showing IgA antibodies to desmoglein 1 and 3","volume":"6","author":"Hegazy","year":"2016","journal-title":"Dermatol Pract Concept"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0738-081X(99)00122-4","article-title":"Dermatoses with intraepidermal IgA deposits","volume":"18","author":"Nishikawa","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0220","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.1365-2230.2002.01061.x","article-title":"Clinical, histopathological and immunological distinction in two cases of IgA pemphigus","volume":"27","author":"Hashimoto","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0225","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1590\/abd1806-4841.20142459","article-title":"Non-classical forms of pemphigus: pemphigus herpetiformis, IgA pemphigus, paraneoplastic pemphigus and IgG\/IgA pemphigus","volume":"89","author":"Porro","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0230","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40257-016-0202-8","article-title":"Subcorneal pustular dermatosis: a review of 30 years of progress","volume":"17","author":"Watts","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0235","first-page":"203","article-title":"Subcorneal pustular dermatosis: a clinical study of ten patients","volume":"61","author":"Lutz","year":"1998","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0240","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0923-1811(95)00449-1","article-title":"Studies of autoantigens recognized by IgA anti-keratinocyte cell surface antibodies","volume":"12","author":"Hashimoto","year":"1996","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0245","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archderm.1987.01660320104022","article-title":"Intercellular IgA dermatosis with clinical features of subcorneal pustular dermatosis","volume":"123","author":"Hashimoto","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0250","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJM198512263132606","article-title":"Intraepidermal neutrophilic IgA dermatosis","volume":"313","author":"Huff","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0255","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0190-9622(89)70014-1","article-title":"IgA pemphigus foliaceus. Report of two cases and a review of the literature","volume":"20","author":"Beutner","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0260","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0190-9622(92)70301-U","article-title":"Intraepidermal IgA pustulosis","volume":"27","author":"Wallach","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0265","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/bjd.14780","article-title":"Clinical and immunological studies of 49 cases of various types of intercellular IgA dermatosis and 13 cases of classical subcorneal pustular dermatosis examined at Kurume University","volume":"176","author":"Hashimoto","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0270","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2014.01.011","article-title":"Diagnosis and classification of pemphigus and bullous pemphigoid","volume":"13","author":"Kershenovich","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0275","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12026-018-8986-7","article-title":"Pemphigus group: overview, epidemiology, mortality, and comorbidities","volume":"66","author":"Kridin","year":"2018","journal-title":"Immunol Res"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0285","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/bjd.14162","article-title":"Clinical and immunological findings in 104 cases of paraneoplastic pemphigus","volume":"173","author":"Ohzono","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0290","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jdcr.2017.11.002","article-title":"Paraneoplastic pemphigus mimicking toxic epidermal necrolysis: an underdiagnosed entity?","volume":"4","author":"McLarney","year":"2018","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0295","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","volume":"43","author":"Joly","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0300","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1346-8138.2012.01655.x","article-title":"Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus","volume":"39","author":"Choi","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0305","first-page":"1103","article-title":"Evaluation of a newly available ELISA for envoplakin autoantibodies for the diagnosis of paraneoplastic pemphigus","volume":"14","author":"Powell","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0310","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cca.2009.08.022","article-title":"Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus","volume":"410","author":"Probst","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0315","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1056\/NEJM199012203232503","article-title":"Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia","volume":"323","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0320","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00403-008-0901-y","article-title":"Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus","volume":"301","author":"Huang","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0325","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/bjd.14282","article-title":"Direct and indirect immunofluorescence staining patterns in the diagnosis of paraneoplastic pemphigus","volume":"174","author":"Poot","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0330","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0190-9622(93)70095-B","article-title":"Indirect immunofluorescence on rat bladder transitional epithelium: a test with high specificity for paraneoplastic pemphigus","volume":"28","author":"Liu","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0335","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(95)90066-7","article-title":"Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus","volume":"32","author":"Helou","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0340","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/PAT.0000000000000196","article-title":"Comparative study of five serological assays for the diagnosis of paraneoplastic pemphigus","volume":"47","author":"Kelly","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0345","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/bjd.13711","article-title":"Anti-desmocollin autoantibodies in nonclassical pemphigus","volume":"173","author":"Ishii","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s12016-017-8633-4","article-title":"Autoimmune subepidermal bullous diseases of the skin and mucosae: clinical features, diagnosis, and management","volume":"54","author":"Amber","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0355","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40257-017-0264-2","article-title":"Bullous pemphigoid: a review of its diagnosis, associations and treatment","volume":"18","author":"Bernard","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0360","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2013.07.009","article-title":"Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid","volume":"69","author":"S\u00e1rdy","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0365","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/all.13131","article-title":"Evidence for a role of eosinophils in blister formation in bullous pemphigoid","volume":"72","author":"de Graauw","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0370","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/bjd.13717","article-title":"Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology","volume":"172","author":"Feliciani","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0375","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/ced.13371","article-title":"Increased sensitivity and high specificity of indirect immunofluorescence in detecting IgG subclasses for diagnosis of bullous pemphigoid","volume":"43","author":"Jank\u00e1skov\u00e1","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0380","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2340\/00015555-2223","article-title":"Complement fixation test: an update of an old method for diagnosis of bullous pemphigoid","volume":"96","author":"Jank\u00e1skov\u00e1","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0385","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/1203475418773359","article-title":"Bullous pemphigoid: a 10-year study of discordant results on direct immunofluorescence","volume":"22","author":"Fudge","year":"2018","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0390","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/ced.12510","article-title":"Diagnostic accuracy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid","volume":"40","author":"Esmaili","year":"2015","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0395","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/bjd.16553","article-title":"Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score","volume":"179","author":"Holtsche","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0400","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3389\/fmed.2018.00139","article-title":"High index values of enzyme-linked immunosorbent assay for BP180 at baseline predict relapse in patients with bullous pemphigoid","volume":"5","author":"Koga","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0405","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archdermatol.2009.53","article-title":"Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study","volume":"145","author":"Bernard","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0410","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00403-016-1631-1","article-title":"Evaluation of ELISA testing for BP180 and BP230 as a diagnostic modality for bullous pemphigoid: a clinical experience","volume":"308","author":"Keller","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0415","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/jamadermatol.2018.4390","article-title":"Assessment of diagnostic strategy for early recognition of bullous and nonbullous variants of pemphigoid","volume":"155","author":"Meijer","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0420","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1111\/ijd.13283","article-title":"Sensitivities and utility of non-invasive serological tests in the diagnosis of bullous pemphigoid","volume":"55","author":"Yew","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0425","doi-asserted-by":"crossref","unstructured":"van Beek N, D\u00e4hnrich C, Johannsen N, et al. Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases. J Am Acad Dermatol. 2017;76:889-894.e885.","DOI":"10.1016\/j.jaad.2016.11.002"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0430","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archderm.141.6.705","article-title":"Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy","volume":"141","author":"Powell","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0435","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.clim.2008.04.012","article-title":"Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid","volume":"128","author":"Di Zenzo","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0440","first-page":"1077","article-title":"Diagnosis of autoimmune bullous diseases","volume":"16","author":"van Beek","year":"2018","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0445","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2133.2009.09566.x","article-title":"Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses","volume":"162","author":"Grootenboer-Mignot","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0450","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1440-0960.2008.00452.x","article-title":"Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting","volume":"49","author":"Desai","year":"2008","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0455","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/bjd.13374","article-title":"Clinical and immunological profiles of 25 patients with pemphigoid gestationis","volume":"172","author":"Tani","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0460","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0738-081X(00)00195-4","article-title":"Herpes gestationis","volume":"19","author":"Lin","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0465","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13023-014-0136-2","article-title":"Gestational pemphigoid","volume":"9","author":"Huilaja","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0470","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/CCID.S128144","article-title":"Pemphigoid gestationis: current perspectives","volume":"10","author":"S\u00e4vervall","year":"2017","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0475","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clindermatol.2016.02.010","article-title":"Pemphigoid gestationis: toward a better understanding of the etiopathogenesis","volume":"34","author":"Sadik","year":"2016","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0480","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jri.2016.04.286","article-title":"Retrospective analysis of pemphigoid gestationis in 32 Saudi patients - clinicopathological features and a literature review","volume":"116","author":"Al-Saif","year":"2016","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0485","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2165\/11532010-000000000-00000","article-title":"Pregnancy dermatoses: diagnosis, management, and controversies","volume":"12","author":"Roth","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0490","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijwd.2016.11.004","article-title":"Pemphigoid gestationis: clinical and histologic features of twenty-three patients","volume":"3","author":"Hallaji","year":"2017","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0495","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jaad.2006.07.015","article-title":"Clinical experience in pemphigoid gestationis: report of 10 cases","volume":"55","author":"Castro","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0500","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2005.12.012","article-title":"The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients","volume":"54","author":"Ambros-Rudolph","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0505","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/DAD.0b013e3182a6b6cc","article-title":"The utility of C4d immunohistochemistry on formalin-fixed paraffin-embedded tissue in the distinction of polymorphic eruption of pregnancy from pemphigoid gestationis","volume":"35","author":"Kwon","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0510","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-4632.2008.03824.x","article-title":"Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis","volume":"47","author":"Barnadas","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0515","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/15665240113136660079","article-title":"Molecular diagnosis in autoimmune skin blistering conditions","volume":"14","author":"Otten","year":"2014","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0520","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaad.2016.09.030","article-title":"Sensitivity and specificity of BP180 NC16A enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis","volume":"76","author":"Al Saif","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0525","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.AOG.0000115506.76104.ad","article-title":"Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis","volume":"103","author":"Sitaru","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0530","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.0022-202X.2005.23646.x","article-title":"Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISA","volume":"124","author":"Bekou","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0535","article-title":"Comparison of histopathology, immunofluorescence, and serology for the diagnosis of autoimmune bullous disorders: an update","volume":"3","author":"Seline","year":"2016","journal-title":"Global Dermatology"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0540","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2013.1434","article-title":"Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid","volume":"149","author":"Bernard","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0545","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.md.0000076003.64510.00","article-title":"Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations","volume":"82","author":"Egan","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0550","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jaad.2017.02.019","article-title":"Spectrum of orocutaneous disease associations: immune-mediated conditions","volume":"77","author":"Cizenski","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0555","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1067\/mjd.2000.107248","article-title":"Cicatricial pemphigoid","volume":"43","author":"Fleming","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0560","first-page":"762","article-title":"Clinical and immunological studies of 332 Japanese patients tentatively diagnosed as anti-BP180-type mucous membrane pemphigoid: a novel BP180 C-terminal domain enzyme-linked immunosorbent assay","volume":"96","author":"Yasukochi","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0565","first-page":"768","article-title":"Autoantibody profile of a cohort of 78 Italian patients with mucous membrane pemphigoid: correlation between reactivity profile and clinical involvement","volume":"96","author":"Cozzani","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0570","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.autrev.2019.02.005","article-title":"Pemphigus and mucous membrane pemphigoid: an update from diagnosis to therapy","volume":"18","author":"Buonavoglia","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0575","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archderm.138.3.370","article-title":"The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","volume":"138","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0580","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13023-018-0855-x","article-title":"Molecular diagnosis of anti-laminin 332 (epiligrin) mucous membrane pemphigoid","volume":"13","author":"Chiorean","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0585","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jaad.2008.02.035","article-title":"IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid","volume":"58","author":"Lazarova","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0590","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.oooo.2013.12.402","article-title":"Diagnosis of oral mucous membrane pemphigoid by means of combined serologic testing","volume":"117","author":"Hayakawa","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0595","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0923-1811(03)00158-0","article-title":"Usefulness of immunoblotting using purified laminin 5 in the diagnosis of anti-laminin 5 cicatricial pemphigoid","volume":"33","author":"Hisamatsu","year":"2003","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0600","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1046\/j.1365-2133.2001.04471.x","article-title":"Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180","volume":"145","author":"Schmidt","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0605","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2133.2000.03661.x","article-title":"IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis","volume":"143","author":"Christophoridis","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0610","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1902\/jop.2004.75.10.1302","article-title":"Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity","volume":"75","author":"Carrozzo","year":"2004","journal-title":"J Periodontol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0615","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1365-2133.2005.06998.x","article-title":"Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity","volume":"154","author":"Oyama","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0620","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1529-8019.2010.01323.x","article-title":"The management of mucous membrane pemphigoid and pemphigus","volume":"23","author":"Knudson","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0625","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/jop.12780","article-title":"The identification of autoantigens in mucous membrane pemphigoid using immortalized oral mucosal keratinocytes","volume":"48","author":"Kamaguchi","year":"2019","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0630","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/1744666X.2016.1221343","article-title":"Clinical features and diagnosis of epidermolysis bullosa acquisita","volume":"13","author":"Vorobyev","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0635","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2230.2010.03845.x","article-title":"Clinical and immunopathological evaluation of epidermolysis bullosa acquisita","volume":"36","author":"Delgado","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0640","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1067\/mjd.2001.117518","article-title":"Immunofluorescence in dermatology","volume":"45","author":"Mutasim","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0645","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.path.2017.01.011","article-title":"Immunofluorescence of autoimmune bullous diseases","volume":"10","author":"Diercks","year":"2017","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0650","doi-asserted-by":"crossref","unstructured":"Meijer JM, Atefi I, Diercks GFH, et al. Serration pattern analysis for differentiating epidermolysis bullosa acquisita from other pemphigoid diseases. J Am Acad Dermatol. 2018;78:754-759.e756.","DOI":"10.1016\/j.jaad.2017.11.029"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0655","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jaad.2016.01.005","article-title":"Comparison of 3 type VII collagen (C7) assays for serologic diagnosis of epidermolysis bullosa acquisita (EBA)","volume":"74","author":"Seta","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0660","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/jdv.12129","article-title":"Sensitivity of different assays for the serological diagnosis of epidermolysis bullosa acquisita: analysis of a cohort of 24 Italian patients","volume":"28","author":"Calabresi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0665","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1111\/j.1468-3083.2012.04617.x","article-title":"Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions","volume":"27","author":"Kim","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0670","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/bjd.15800","article-title":"Serological diagnostics in the detection of IgG autoantibodies against human collagen VII in epidermolysis bullosa acquisita: a multicentre analysis","volume":"177","author":"Schmidt","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0675","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bjd.12300","article-title":"Low sensitivity of type VII collagen enzyme-linked immunosorbent assay in epidermolysis bullosa acquisita: serration pattern analysis on skin biopsy is required for diagnosis","volume":"169","author":"Terra","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0680","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jaad.2011.12.032","article-title":"Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita","volume":"68","author":"Komorowski","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0685","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jdermsci.2011.03.003","article-title":"Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients","volume":"62","author":"Saleh","year":"2011","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0690","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaad.2008.12.037","article-title":"Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet","volume":"61","author":"Rose","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0695","doi-asserted-by":"crossref","first-page":"609","DOI":"10.23736\/S0392-0488.16.05497-3","article-title":"Are antiepidermal transglutaminase antibodies titre correlated with dermatitis herpetiformis lesions during the disease follow-up?","volume":"153","author":"Cozzani","year":"2018","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0700","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1365-4632.2007.03214.x","article-title":"Clinical, pathologic, and immunopathologic features of dermatitis herpetiformis: review of the Mayo Clinic experience","volume":"46","author":"Alonso-Llamazares","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0705","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000372-200208000-00003","article-title":"Characterization of a subgroup of patients with dermatitis herpetiformis with nonclassical histologic features","volume":"24","author":"Warren","year":"2002","journal-title":"Am J Dermatopathol"},{"issue":"265-270","key":"10.1016\/j.clindermatol.2019.09.004_bb0710","first-page":"265","article-title":"Clinical, histological and immunpathological findings in 32 patients with dermatitis herpetiformis Duhring","volume":"8","author":"Rose","year":"2010","journal-title":"J Dtsch Dermatol Ges."},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0715","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1590\/abd1806-4841.20142966","article-title":"Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment","volume":"89","author":"Clarindo","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0720","first-page":"163","article-title":"Clinical and immunopathological features of 159 patients with dermatitis herpetiformis: an Italian experience","volume":"148","author":"Antiga","year":"2013","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0725","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3389\/fimmu.2019.01290","article-title":"Dermatitis herpetiformis: novel perspectives","volume":"10","author":"Antiga","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0730","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2133.2001.03981.x","article-title":"Tissue transglutaminase antibody assessment in dermatitis herpetiformis","volume":"144","author":"Caproni","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0735","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00004836-200303000-00007","article-title":"Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease","volume":"36","author":"Tursi","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0740","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-4362.2003.01804.x","article-title":"Dermatitis herpetiformis","volume":"42","author":"Nicolas","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0745","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1468-3083.2009.03188.x","article-title":"Guidelines for the diagnosis and treatment of dermatitis herpetiformis","volume":"23","author":"Caproni","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0750","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1006\/clim.2000.4983","article-title":"Tissue transglutaminase and endomysial antibodies-diagnostic markers of gluten-sensitive enteropathy in dermatitis herpetiformis","volume":"98","author":"Kumar","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0755","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.20011299","article-title":"Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis","volume":"195","author":"S\u00e1rdy","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0760","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1610-0387.2005.05762.x","article-title":"Transglutaminases as diagnostically relevant autoantigens in patients with gluten sensitivity","volume":"3","author":"Heil","year":"2005","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0765","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2133.2008.08629.x","article-title":"Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis","volume":"159","author":"Hull","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0770","article-title":"Celiac-related autoantibodies and IL-17A in Bulgarian patients with dermatitis herpetiformis: a cross-sectional study","volume":"55","author":"Velikova","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0775","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.det.2011.03.013","article-title":"Linear IgA disease: clinical presentation, diagnosis, and pathogenesis","volume":"29","author":"Venning","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0780","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0785","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fmed.2018.00296","article-title":"Diagnosis of autoimmune blistering diseases","volume":"5","author":"Witte","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0790","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/jid.2014.381","article-title":"Type VII collagen is the major autoantigen for sublamina densa-type linear IgA bullous dermatosis","volume":"135","author":"Tsuchisaka","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0795","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0738-081X(00)00185-1","article-title":"Linear IgA bullous dermatosis","volume":"19","author":"Guide","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0800","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/abd1806-4841.2019940208","article-title":"Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology","volume":"94","author":"Vale","year":"2019","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0805","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjd.15244","article-title":"Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults","volume":"177","author":"Gottlieb","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0810","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13023-019-1089-2","article-title":"Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients","volume":"14","author":"Genovese","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0815","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-6-31","article-title":"Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases","volume":"6","author":"Csorba","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0820","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/bjd.15232","article-title":"A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence","volume":"177","author":"Ohata","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0825","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1046\/j.1365-2133.2003.05316.x","article-title":"Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting","volume":"148","author":"Oyama","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0830","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1600-0625.2010.01080.x","article-title":"IgA autoantibodies in the pemphigoids and linear IgA bullous dermatosis","volume":"19","author":"Horv\u00e1th","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0835","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijwd.2017.10.001","article-title":"New biochip immunofluorescence test for the serological diagnosis of pemphigus vulgaris and foliaceus: a review of the literature","volume":"4","author":"Xuan","year":"2018","journal-title":"Int J Womens Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0840","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1750-1172-7-49","article-title":"Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy","volume":"7","author":"van Beek","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0845","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jim.2012.05.007","article-title":"Autoantibody detection in bullous pemphigoid: clinical evaluation of the EUROPLUS\u2122 Dermatology Mosaic","volume":"382","author":"Damoiseaux","year":"2012","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0850","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/cup.12637","article-title":"Automated direct immunofluorescence analyses of skin biopsies","volume":"43","author":"Lemcke","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0855","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/DAD.0b013e31818ffde1","article-title":"The utility of the DNA microarray scanner to simplify the immunofluorescence evaluation of autoimmune bullous diseases","volume":"31","author":"Iwamoto","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0860","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdermsci.2016.12.007","article-title":"Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid","volume":"85","author":"Fujio","year":"2017","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0865","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/exd.13488","article-title":"A novel lateral flow immunoassay for the rapid detection of anti-Dsg3 IgG serum autoantibodies in pemphigus vulgaris","volume":"27","author":"Schmidt","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0870","unstructured":"Murrell DF, Pe\u00f1a S, Joly P, et al. Diagnosis and management of pemphigus: recommendations by an international panel of experts. J Am Acad Dermatol, in press."},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0875","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0738-081X(00)00179-6","article-title":"Direct immunofluorescence microscopy in the diagnosis of autoimmune bullous dermatoses","volume":"19","author":"Morrison","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0880","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1468-3083.2007.02553.x","article-title":"Clinical and immunopathological heterogeneity of 22 cases of linear IgA bullous dermatosis","volume":"22","author":"Sobjanek","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2019.09.004_bb0885","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/1346-8138.12278","article-title":"Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita","volume":"40","author":"Ito","year":"2013","journal-title":"J Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X19301762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X19301762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:15:44Z","timestamp":1760033744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X19301762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":177,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0738081X19301762"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2019.09.004","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the diagnosis of autoimmune bullous dermatoses","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}